A Therapeutic Alternative in the Management of Fibromyalgia

A Therapeutic Alternative in the Management of Fibromyalgia

Contenido principal del artículo

Jair Malagón
Mariana Villaveces
Lluis Manent


Introduction: Fibromyalgia is a condition that affects up to 5% of the population and causes significant deterioration of the quality of life for the sufferer, so it is a therapeutic challenge. The objective of the present study was to describe the experience of the AtlasPROfilax® method in patients with fibromyalgia diagnosed according to the criteria of the American College of Reumatology (ACR) 2010.

Methodology: A cross - sectional study with 63 patients with fibromyalgia was done. Patients were monitored two and six months after applying the AtlasPROfilax® method, in order to evaluate the pain level by visual analogue scale VAS and reevaluate ACR criteria in the follow-up appointment.

Results: The average age of patients was 48.5 SD 12.6 years, 95.24% were female. 100% of patients improved pain (initial VAS of 8 vs 4 and 3 after two and six months respectively) and these were significant results. A reduction of widespread pain index as well as a reduction in the presence of symptoms such as fatigue, non-restorative sleep and cognitive disorders that are typical of fibromyalgia were also found in 46% of cases

Conclusion: This study has provided evidence of the effectiveness of the neuromuscular stimulation method of the suboccipital musculature called AtlasPROfilax® in the treatment of fibromyalgia. Randomized and controlled studies are required to demonstrate the medium and long term effectiveness of this therapeutic alternative.


Los datos de descargas todavía no están disponibles.

Detalles del artículo

Biografía del autor/a (VER)

Jair Malagón, Barcelona University

Director de la Atlasprofilax Academy Switzerland Latin America y docente o facilitador en Convenio con la Fundación Universitaria Juan N Corpas para el Diplomado "La Desalineación Menor del Atlas" en el Dept. de Formación continuada de la misma.

Mariana Villaveces, Rosario University

Epidemiologist, Quality Health Manager at Rosario University

Lluis Manent, Barcelona University. National Institute of Homeopathy. Juan N Corpas University Foundation

Director at Atlasprofilax Academy Switzerland Latin America. President of International Association of Qualified Atlasprofs. Teacher of University Course "The Correction of Minor Intervertebral Disorder of C1"

Referencias (VER)

Escudero-Carretero MJ, García-Toyos N, Prieto-Rodríguez MA, Pérez-Corral O, March-Cerdá JC L-DM. Fibromyalgia: Patient perception on their disease and health system. Qualitative research study. Reumatol Clin. 2010;6(1):16–22.

Martin AP, Lanza JRL. Evidences in fibromyalgia. FMC Form Med Contin Aten Prim. 2007;14(8):465–73.

Häuser W, Eich W, Herrmann M, Nutzinger DO, Schiltenwolf M HP. The Fibromyalgia syndrome: Classification, diagnosis, and treatment. Dtsch Arztebl. 2009;106(23):383–91.

Rivera J, Alegre C, Nishishinya MB PC. Therapeutic evidence in fibromyalgia. Reum Clin. 2006;2(SPEC.ISS1):34–7.

Baranowsky J, Klose P, Musial F, Haeuser W, Dobos G LJ. Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia. Rheumatol Int. 2009;30(1):1–21.

Sarac AJ GA. Complementary and alternative medical therapies in fibromyalgia. Curr Pharm Des. 2006;12(1):47–57.

Wang C, Schmid CH, Rones R, Kalish R, Yinh J, Goldenberg DL et al. A randomized trial of tai chi for fibromyalgia. N Engl J Med. 2010;363(8):743–54.

Patel NB. Guide to Pain Management in Low-Resource Settings.

Matsumoto S, Shimodozono M, Etoh S, Miyata R KK. Effects of thermal therapy combining sauna therapy and underwater exercise in patients with fibromyalgia. Complement Ther Clin Pr. 2010;10(3):201–8.

Saudo Corrales B, Galiano Orea D, Carrasco Pez L, Saxton J DHLM. Autonomous nervous system response and quality of life on women with fibromyalgia after a long-term intervention with physical exercise. Rehabilitación. 2010;44(3):244–9.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Kazt RS, Mease P et al. The American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.

Arnold, Lesley M; Stanford, Sharon B; Welge, Jeffrey A; Crofford LJ. Development and testing of the fibromyalgia diagnostic screen for primary care. J Womens Heal. 2012;21(2):231–9.

Segura-Jiménez, Víctor; Aparicio, Virginia A; Álvarez-Gallardo, Inmaculada C; Soriano-Maldonado, Alberto; Estévez-López, Fernando; Delgado-Fernández, Manuel; Carbonell-Baeza A. Validation of the modified 2010 American College of Rheumatology diagnostic criteria for fibromyalgia in a Spanish population. Rheumatology. 2014;53(10):1803–11.

Carrillo-de-la-Peña, M T; Triñanes, Y; González-Villar, A; Romero-Yuste, S; Gómez-Perretta, C; Arias, M; Wolfe F. Convergence between the 1990 and 2010 ACR diagnostic criteria and validation of the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ). Rheumatol Int. 2015;35(1):141–51.

Bennett, RM; Friend, R; Marcus, D; Bernstein, C; Han, BK; Yachoui, R; Deodhar, A; Kaell A et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res. 2014;66(9):1364–73.

Juan C. Restrepo-Medrano, Elena Ronda-Pérez, Carmen Vives-Cases y DG-G. ¿Qué sabemos sobre los Factores de Riesgo de la Fibromialgia? Rev Salud Publica. 2009;11(4):662–74.

R S. Atlasprofilax. Asociación Latinoamericana de Especialistas en AtlasProfilax. Asociación Latinoamericana de Especialistas en AtlasProfilax. 2011. p. www.atlasprofilax.la.

Navas VEG. Efecto de la terapia Atlasprofilax® sobre los síntomas relacionados con disfunción temporomandibular, bruxismo y la relación de las líneas medias dentales. UstaSalud. 2013;12(2):124–33.

Guymer E LG. Fibromyalgia: Current diagnosis and management. Expert. Rev Clin immunol. 2009;5(2):181–92.

Gómez-Argüelles JM AB. Prevalence of neurological symptoms associated with fibromyalgia. Rev Soc Esp Dolor. 2009;16(4):222–9.

Ware MA, Fitzcharles M-, Joseph L SY. The effects of nabilone on sleep in fibromyalgia: Results of a randomized controlled trial. Anesth Analg. 2010;110(2):604–10.

Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M et al. Prevalence of fibromyalgia: A survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448–53.

A Collado, J Alijotas, P Benito, C Alegre, M Romera, I Sañudo, R Martín, J M Peri, J M Cots, J Maria Peri JMC. Documento de consenso sobre el diagnóstico y tratamiento de la fibromialgia en Cataluña. Med Clin. 2002;118(19):745–9.

Downie WW, Leatham P a, Rhind VM, Wright V, Branco J a, Anderson J a. Studies with pain rating scales. Ann Rheum Dis. 1978;37(4):378–81.

A.M. Martín-Nogueras, JIC-A. Efficacy of physiotherapy treatment on pain and quality of life in patients with fibromyalgia. Rehabilitacion. 2012;46(3):199–206.

Workspace.1 NRMA links open the author workspace. O the author workspaceOpens the author workspace1. N and letters correspond to the affiliation list. C to expose these in author workspaceMauricio ÁMA links op. Acupuncture as complementary treatment of fibromyalgya. Rev Colomb Reumatol. 2012;19(1):27–

Jaime Gonzalez Gonzalez, Maria del Mar del Teso Rubio, Carmen Nelida Waliño Paniagua, Juan Jose Criado-Alvarez JSH. Symptomatic pain and fibromyalgia treatment through multidisciplinary approach for Primary Care. Reumatol Clin. 2015;11(1):22–6.